UNSPSC 51422209: Fluorometholone acetate

This classification denotes a therapeutic glucocorticoid C24H31FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9I50C3I3OK, chemically known as pregna-1,4-diene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-6-methyl-, (6.alpha.,11.beta.)-, but more generally known as fluorometholone acetate, which bears US NIH Compound Identifier 240767. European Medicines Agency schedules Fluorometholone acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13906MIG.

UNSPSC 51422209 Fluorometholone acetate is a Commodity code for a topical ophthalmic corticosteroid pharmaceutical product, though the recent state and local opportunities tagged under this code do not align with its nominal scope. The single recent opportunity on file shows Seminole County, Florida procuring naloxone and drug deactivation systems—products unrelated to fluorometholone acetate or ophthalmic pharmaceuticals. This mismatch suggests either a miscoding issue in the state and local procurement system or that the code is not actively used for its intended product category in the jurisdictions tracked here.

No recent state and local solicitations for fluorometholone acetate or related ophthalmic corticosteroids appear in the activity record. The only posted opportunity under this code—Seminole County IFB 60459723LAS, posted June 30, 2026, with response due July 26, 2023—covers naloxone and drug deactivation systems for community health initiatives, representing a distinct pharmaceutical class and use case. Until activity more closely aligned with the code's stated product scope appears, firms pursuing ophthalmic pharmaceutical contracts should verify the correct UNSPSC classification with the issuing jurisdiction before responding to notices tagged as fluorometholone acetate.